FILTRIX Logo FILTRIX Find Your Edge →
Ticker Report — Historical Last signal ·

$ENGN

Trade-Ideas alerts 60.0% at 5-min n=10 2023-12-05 → 2026-06-18

⚠ SMALL SAMPLE · 10 alerts only. Statistics may have high variance — interpret with caution.

🏢 Company Profile

enGene Therapeutics Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (SIC 2836)
📍 NASDAQ 📅 IPO: Nov 01, 2023 🔗 www.engene.com
💰 Market Cap: $130.0M 👥 Employees: 82
enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.
Total alerts
10
Trade-Ideas signal history
Win rate · 5MIN
60.0%
Best timeframe baseline
Avg gain · 5MIN
+1.12%
Per-alert expectancy
Avg MFE
+5.70%
Max potential excursion

Practice trading ENGN on historical setups — browse all patterns across all tickers →

📈 Performance by Timeframe

5MIN

Win Rate: 60.0%
Avg Gain: +1.12%
Avg Winner: +2.83%
Avg Loser: -1.91%
Best: +7.37%
Worst: -3.73%
Trades: 6/3

15MIN

Win Rate: 44.4%
Avg Gain: -1.08%
Avg Winner: +2.54%
Avg Loser: -3.98%
Best: +3.89%
Worst: -14.09%
Trades: 4/5

30MIN

Win Rate: 55.6%
Avg Gain: -0.55%
Avg Winner: +2.35%
Avg Loser: -5.55%
Best: +4.13%
Worst: -12.05%
Trades: 5/3

60MIN

Win Rate: 44.4%
Avg Gain: -1.53%
Avg Winner: +3.14%
Avg Loser: -6.58%
Best: +4.51%
Worst: -13.86%
Trades: 4/4

EOD (End of Day)

Win Rate: 30.0%
Avg Gain: -2.84%
Avg Winner: +7.58%
Avg Loser: -8.52%
Best: +14.66%
Worst: -21.82%
Trades: 3/6

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +5.70%
Best MFE: +16.82%
Avg Time to MFE: 83 min

On average, ENGN alerts reach +5.70% profit potential within 83 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -2.98%
Worst MAE: -16.05%
Avg Time to MAE: 9 min

Before reaching MFE, expect an average drawdown of 2.98%.

⚖️ Risk/Reward Ratio

1.91:1

Good risk/reward - favorable for momentum trading.

💡 Trading Insight: Based on 10 alerts, ENGN typically reaches +5.70% profit before pulling back. Consider setting profit targets around 4.6% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 10
Gap Up % 40.0%
Avg Gap -0.48%
Best Gap +1.74%

🏭 Sector Comparison: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

How ENGN compares to 144 other tickers in the same sector.

5-Min Gain
ENGN: +1.07% Sector: -0.29% +1.36%
EOD Gain
ENGN: -2.23% Sector: +750.04% -752.27%
Avg MFE
ENGN: +6.08% Sector: +6.58% -0.50%

📋 Last 20 Alerts

Historical ENGN alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2026-06-18 09:25:00 $1.72 +2.33% +2.62% +2.03% +2.62% +0.00% +5.23% +0.00% +1.74% WIN
2026-06-15 09:25:00 $1.75 +1.71% +1.14% +0.29% +1.14% +1.14% +4.00% -1.71% +0.00% WIN
2026-05-13 09:25:00 $1.44 +0.00% +2.50% +2.43% +4.51% +6.94% +11.11% +0.00% +0.00% LOSS
2026-05-12 09:25:00 $1.48 -1.35% -0.68% -1.35% +0.00% -2.70% +1.35% -1.35% -2.03% LOSS
2026-05-11 09:25:00 $1.51 -0.66% -1.32% +0.00% +4.30% -1.32% +4.64% -2.65% +0.00% LOSS
2026-05-08 09:25:00 $1.7 +2.63% -2.66% -3.25% -0.61% -11.78% +2.92% +0.00% +0.57% WIN
2026-05-07 09:25:00 $2.2 +1.36% -14.09% -12.05% -13.86% -21.82% +1.82% -4.55% -2.27% WIN
2026-03-05 09:25:00 $9.5 +1.58% - - - -8.32% +2.32% +1.58% +1.58% WIN
2024-02-14 09:27:44 $14.39 +7.37% +3.89% +2.85% -10.95% +14.66% +16.82% -16.05% -4.45% WIN
2023-12-05 09:29:00 $12.34 -3.73% -1.13% +4.13% -0.90% -5.19% +6.81% -5.11% +0.08% LOSS

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

Beat the 60.0% Baseline on ENGN

The 60.0% win rate is just the raw starting point. Launch the app to apply filters (Volume, RSI, Time) and push ENGN's performance to 75%+.

Optimize ENGN Strategy →

Why Analyze ENGN with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for ENGN. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, ENGN historically offers an average upside of +5.70% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 ENGN Momentum Personality

With a baseline win rate of 60.0%, ENGN shows neutral behavior, suggesting the need for additional volume confirmation.

⏱️ Optimized Exit Timing

Don't guess when to sell. Our backtests show ENGN performs best on the 5MIN timeframe (Avg Gain: +1.12%), signaling that gains often fade later in the session.